Additive improvement induced by bezafibrate in patients with primary biliary cirrhosis showing refractory response to ursodeoxycholic acid.
第一作者:
Yasuto,Takeuchi
第一单位:
Department of Internal Medicine, Okayama Saiseikai General Hospital, Okayama, Japan.
作者:
主题词
成年人(Adult);老年人(Aged);碱性磷酸酶(Alkaline Phosphatase);苯扎贝特(Bezafibrate);抗药性(Drug Resistance);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);人类(Humans);免疫球蛋白M(Immunoglobulin M);日本(Japan);肝硬化, 胆汁性(Liver Cirrhosis, Biliary);Logistic模型(Logistic Models);男(雄)性(Male);中年人(Middle Aged);前瞻性研究(Prospective Studies);时间因素(Time Factors);治疗失败(Treatment Failure);熊脱氧胆酸(Ursodeoxycholic Acid)
DOI
10.1111/j.1440-1746.2011.06737.x
PMID
21443659
发布时间
2022-04-10
- 浏览22
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文